Understanding the anti-tumour immune response to radionuclide therapy using PSMA targeting radiopharmaceuticals in a prostate cancer model
<p>The ability of external beam radiation (EBRT) to modulate the tumour immune microenvironment is becoming increasingly well understood, leading to the development of combinatorial EBRT and immunotherapeutic combinations to improve patient responses. Despite this, there is very limited unders...
المؤلف الرئيسي: | |
---|---|
مؤلفون آخرون: | |
التنسيق: | أطروحة |
اللغة: | English |
منشور في: |
2021
|
الموضوعات: |